A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine

Trial Profile

A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Poliovirus vaccine (Primary)
  • Indications Poliomyelitis
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Sponsors Bilthoven Biologicals
  • Most Recent Events

    • 10 Nov 2017 Planned End Date changed from 1 Mar 2018 to 30 Mar 2018.
    • 10 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 15 Feb 2018.
    • 10 Nov 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top